Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Blast Pharma Ltd (NASDAQ:ORPN)

1.81
Delayed Data
As of May 23
 +0.03 / +1.69%
Today’s Change
1.65
Today|||52-Week Range
8.50
-53.23%
Year-to-Date
No recent news for Bio Blast Pharma Ltd.

Today’s Trading

Previous close1.78
Today’s open1.87
Day’s range1.78 - 1.88
Volume56,735
Average volume (3 months)281,146
Market cap$29.2M
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)-89.47%
Earnings growth (this year)-13.43%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
AVDXAvant Diagnostics In...+0.12+40.00%
ICCCImmuCell Corp-0.24-3.47%
ONSIUOncobiologics Inc+0.02+0.43%
VTGNVistaGen Therapeutic...0.000.00%
Data as of 10:51am ET, 05/23/2016

Financials

Last reporting dateMay 24, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$15.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Colin J. Foster
Chief Financial Officer
Robert W. Cook
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs